Cardiovascular / Cardiology

HEILBRONN, Germany–(BUSINESS WIRE)–zfhn Zukunftsfonds Heilbronn, one of the largest private venture capitalists in Germany, has sold medical technology company XENIOS AG to Fresenius Medical Care AG & Co. KGaA (Fresenius Medical Care). XENIOS AG is an internationally active medical technology company focusing on the treatment of lung and cardiac failure. In 2008, zfhn took over…

St. Jude Medical issued an advisory Oct. 11 warning of premature battery depletion associated with lithium deposits in a small number of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy ICDs. The issues could affect 0.21 percent of the devices manufactured before May 23, 2015, according to a company news release. St. Jude Medical said…

Tiny pollution particles produced by vehicle engines and industry are known to worsen heart disease and raise the risk of stroke, but a new study suggests they might also be planting the seeds for cardiovascular disease early on. In healthy young adults with no signs of heart disease, researchers found that exposure to fine pollution…

At least four patients have died in U.S. after bacterial infection by heater-cooler instrument.   Researchers linked a rare but potentially lethal bacterial infection that has affected patients in at least three states to contamination of a device used in open-heart surgery centers. At least four patients in the U.S. have died. In a report…

October 14, 2016 — Philips announced at The American College of Emergency Physicians’ (ACEP) annual meeting that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its S4-1 cardiac transducer for Lumify, its smart-device diagnostic ultrasound solution. The pocket-sized and lightweight S4-1 transducer now offers advanced sensitivity and high-resolution 2-D…

October 4, 2016 – Westlake, TX — Heart Test Laboratories, Inc., is pleased to announce that it has submitted its 510(K) application to the Food and Drug Administration (FDA) and a CE Mark certification submission to the British Standards Institute (BSI) group for its MyoVista electrocardiographic device. FDA clearance is required for Heart Test Labs…

Removing plaque from clogged arteries is a common procedure that can save and improve lives. This treatment approach was recently made even safer and more effective with a new, high-tech catheter that allows cardiologists to see inside the arteries for the first time, cutting out only the diseased tissue. Interventional cardiologists at Sulpizio Cardiovascular Center…

The U.S. is a true melting pot. In 2014 alone, more than one million immigrants gained legal permanent residence within its borders. But with that distinction comes an ever-changing set of health concerns that physicians must help treat and manage. The latest, according to a recent article in the journal Circulation, is Chagas heart disease.…

American lives have been getting steadily longer, and since the 1960s that trend has been driven mostly by a remarkable reduction in heart disease. But those improvements have slowed dramatically. Scientists are now wondering whether we’re approaching the end of the trend of longer, healthier lives. That’s because the steady decline in heart disease is…